Alastair Garfield

RYTM

Alastair Garfield serves as Chief Scientific Officer at Rhythm Pharmaceuticals, Inc. (RYTM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$85.5K

Net Position

Net Seller

$85.5K

Companies Traded

RYTM

Active Period

Jul 2025

1 total trades

Most Recent

Sell RYTM

Jul 3, 2025 · $85.5K

Alastair Garfield's Insider Trading at Rhythm Pharmaceuticals, Inc. (RYTM)

Buys

0 · $0.00

Sells

1 · $85.5K

Total Shares Bought

Total Shares Sold

1,319

RYTM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 3, 2025	Sell	1,319	$64.81	$85.5K	3,132

Related Insiders

Christopher Paul German

officer: Corporate Controller & CAO

RYTMSell · Mar 6, 2026

Hunter C Smith

officer: Chief Financial Officer

RYTMSell · Feb 19, 2026

Pamela J. Cramer

Chief Human Resources Officer

RYTMSell · Dec 15, 2025

Joseph Shulman

Chief Technical Officer

RYTMSell · Nov 3, 2025

MCGIRR DAVID W J

Director

RYTMSell · Jun 5, 2025

David P Meeker

President and CEO

RYTMSell · Jun 5, 2025

Yann Mazabraud

EVP, Head of International

RYTMSell · May 1, 2025

Explore More Insider Trading Data

RYTM Insider Trading Activity

View all insider trades at Rhythm Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity